BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31467357)

  • 21. CDH1 and hereditary diffuse gastric cancer: a narrative review.
    Gregory SN; Davis JL
    Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
    BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer.
    Pinheiro H; Bordeira-Carriço R; Seixas S; Carvalho J; Senz J; Oliveira P; Inácio P; Gusmão L; Rocha J; Huntsman D; Seruca R; Oliveira C
    Hum Mol Genet; 2010 Mar; 19(5):943-52. PubMed ID: 19965908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
    Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
    Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of the human E-cadherin (CDH1) gene.
    Berx G; Becker KF; Höfler H; van Roy F
    Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
    Graziano F; Humar B; Guilford P
    Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications.
    Lim HJ; Zhuang L; Fitzgerald RC
    J Exp Clin Cancer Res; 2023 Mar; 42(1):57. PubMed ID: 36869400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview on new progress of hereditary diffuse gastric cancer with
    Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
    Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family's History Based on the
    Caggiari L; Fornasarig M; De Zorzi M; Cannizzaro R; Steffan A; De Re V
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
    Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
    Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
    Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
    Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
    Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary Diffuse Gastric Cancer.
    Decourtye-Espiard L; Guilford P
    Gastroenterology; 2023 Apr; 164(5):719-735. PubMed ID: 36740198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
    Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
    Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
    Guilford P; Humar B; Blair V
    Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PATHOLOGICAL SIGNIFICANCE OF CDH1/E-CADHERIN GERMLINE SEQUENCE VARIANTS IN BREAST CANCER PATIENTS.
    Tabassum S; Munir F; Al Awadh AA; Anwar Z
    Exp Oncol; 2023 Oct; 45(2):170-179. PubMed ID: 37824775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.